文献速递外周动脉疾病血液透析通路

新型局部双效抗血小板抗凝药物APAC在猪血管损伤模型中的多靶点作用

Novel Locally Acting Dual Antiplatelet and Anticoagulant (APAC) Targets Multiple Sites of Vascular Injury in an Experimental Porcine Model.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2019-11-08

本研究在猪股动静脉瘘、髂动脉和颈动脉球囊损伤及体外内皮剥脱模型中,评估双效抗血小板抗凝药物APAC的血管结合特性。结果显示APAC与基质vWF和层粘连蛋白共定位,而不与内皮PECAM-1和podocalyxin共定位,可靶向并穿透损伤血管壁。

要点

  • APAC可结合于动静脉瘘吻合口及体内外损伤动脉。
  • APAC与基质vWF(M1≥0.66)和层粘连蛋白(M1≥0.60)共定位。
  • 内皮PECAM-1或podocalyxin存在时APAC共定位降低(M1≤0.25)。

核心结论

  • APAC快速靶向损伤血管,与基质vWF和层粘连蛋白共定位,而不与内皮PECAM-1和podocalyxin共定位,可能为血管介入提供局部抗血栓作用。

研究设计与样本

  • 实验性猪模型研究,采用三种胶原暴露损伤模型:股动静脉瘘、体内髂动脉和颈动脉球囊血管成形术损伤、体外股动脉内皮剥脱损伤。
  • 生物素化APAC(0.5 mg/mL)在血流恢复前与损伤部位孵育,通过免疫荧光和共聚焦显微镜检测APAC、vWF、层粘连蛋白、PECAM-1和podocalyxin,并计算Manders共定位系数(M1)。

主要发现

  • APAC结合于动静脉瘘吻合口以及体内和体外损伤动脉。
  • APAC与基质vWF共定位(M1≥0.66),与层粘连蛋白共定位(M1≥0.60)。
  • 内皮PECAM-1或podocalyxin存在时APAC共定位较低(M1≤0.25)。
  • APAC靶向并穿透损伤血管壁,尤其是动静脉瘘静脉。

临床怎么用

  • APAC的局部靶向特性可能作为血管介入中局部抗血栓策略的潜在方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Vascular binding of dual antiplatelet and anticoagulant (APAC) was assessed in surgically created femoral arteriovenous fistula (AVF) and iliac and carotid artery injury in porcine models. METHODS: Three models of collagen exposing injury were used: 1) femoral AVF, 2) in vivo iliac and carotid artery balloon angioplasty injury, and 3) in vitro femoral artery endothelial denudation injury. Biotinylated APAC (0.5 mg/mL) was incubated with the injury site before releasing blood flow. APAC, von Willebrand factor (vWF), laminin, platelet endothelial cell adhesion molecule 1 (PECAM-1), and podocalyxin were detected in histological sections using immunofluorescence and confocal microscopy and Manders' co-localisation coefficient (M1). RESULTS: APAC bound to AVF at anastomosis and to both in vivo and in vitro injured arteries. APAC co-localised with matrix vWF (M1 ≥ 0.66) and laminin (M1 ≥ 0.60), but less so if endothelial PECAM-1 or podocalyxin was present (M1 ≤ 0.25). APAC targeted and penetrated the injured vessel wall, especially the AVF vein. CONCLUSIONS: APAC, compatible with its high negative charge, rapidly targets injured vessels co-localizing with matrix vWF and laminin, but not with endothelial PECAM-1 and podocalyxin. This localising feature may have potential antithrombotic implications for vascular interventions.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Barreiro KA, Tulamo R, Jouppila A, et al. Novel Locally Acting Dual Antiplatelet and Anticoagulant (APAC) Targets Multiple Sites of Vascular Injury in an Experimental Porcine Model. Eur J Vasc Endovasc Surg. 2019. PMID: 31708337. doi:10.1016/j.ejvs.2019.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。